Work

Effect of Orforglipron versus Placebo and Dulaglutide on Glycemic Control and Body Weight in Patients with Type 2 Diabetes

Year: 2024

Type: article

Source: Diabetologie und Stoffwechsel

DOI: 10.1055/s-0044-1785387

Authors: Juan Frias, Stanley Hsia, Sarah Eyde, Rong Liu, Xiaosu Ma, Manige Konig, Christof Kazda, Edward Pratt, Kieren J. Mather, Axel Haupt, Deborah Robins, Daniel Robert Quast

Institutions: Velocity Clinical Research (United States), Eli Lilly (United States), St. Josef-Hospital, Katholisches Klinikum Bochum

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4394907418

FWCI:

Cites:

Cited by:

Related to: 10